Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab.
Fissolo N, Pignolet B, Rio J, Vermersch P, Ruet A, deSèze J, Labauge P, Vukusic S, Papeix C, Martinez-Almoyna L, Tourbah A, Clavelou P, Moreau T, Pelletier J, Lebrun-Frenay C, Bourre B, Defer G, Montalban X, Brassat D, Comabella M. Fissolo N, et al. Among authors: clavelou p. Neurol Neuroimmunol Neuroinflamm. 2021 Apr 26;8(4):e1003. doi: 10.1212/NXI.0000000000001003. Print 2021 Jul. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33903203 Free PMC article. Clinical Trial.
[CARIMS (Cancer Risk In Multiple Sclerosis) project: impact of long-term treatment].
Lebrun C, Debouverie M, Vermersch P, Clavelou P, Rumbach L, de Seze J, Defer G, Berthier F; Club Francophone de la Sclérose en Plaques. Lebrun C, et al. Among authors: clavelou p. Rev Neurol (Paris). 2007 Jan;163(1):38-46. doi: 10.1016/s0035-3787(07)90353-7. Rev Neurol (Paris). 2007. PMID: 17304171 Review. French.
Acute fulminant demyelinating disease: a descriptive study of 60 patients.
de Seze J, Debouverie M, Zephir H, Lebrun C, Blanc F, Bourg V, Wiertlewski S, Pittion S, Laplaud D, Le Page E, Deschamps R, Cabre P, Pelletier J, Malikova I, Clavelou P, Jaillon V, Defer G, Labauge P, Gout O, Boulay C, Edan G, Vermersch P. de Seze J, et al. Among authors: clavelou p. Arch Neurol. 2007 Oct;64(10):1426-32. doi: 10.1001/archneur.64.10.1426. Arch Neurol. 2007. PMID: 17923626
Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, de Seze J, Rumbach L, Pelletier J, Labauge P, Brochet B, Tourbah A, Clavelou P; Club Francophone de la Sclérose en Plaques. Lebrun C, et al. Among authors: clavelou p. Arch Neurol. 2009 Jul;66(7):841-6. doi: 10.1001/archneurol.2009.119. Arch Neurol. 2009. PMID: 19597085
Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion.
Calais G, Forzy G, Crinquette C, Mackowiak A, de Seze J, Blanc F, Lebrun C, Heinzlef O, Clavelou P, Moreau T, Hennache B, Zephir H, Verier A, Neuville V, Confavreux C, Vermersch P, Hautecoeur P. Calais G, et al. Among authors: clavelou p. Mult Scler. 2010 Jan;16(1):87-92. doi: 10.1177/1352458509352195. Epub 2009 Dec 22. Mult Scler. 2010. PMID: 20028709
286 results